3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector
- RxCUI
- 847191
- RxNorm name
- 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector
- Display name
- 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector
- Full name
- 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:48
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 021172 | Novolog Mix 70/30 | insulin aspart protamine and insulin aspart | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NovoLog Mix 70/30 | INSULIN ASPART | REMEDYREPACK INC. | 66da64f7-ca50-47d2-95fa-de37005eef85 | 2026-05-18 | Warnings, Adverse reactions | 847191 |
| Insulin Aspart Protamine and Insulin Aspart Mix 70/30 | INSULIN ASPART | REMEDYREPACK INC. | 5d9f0e10-edb9-4960-bd62-cf406e75bbe7 | 2026-04-07 | Warnings, Adverse reactions | 847191 |
| NovoLog Mix 70/30 | INSULIN ASPART | A-S Medication Solutions | 19888a44-b330-462a-864d-338c5893dd63 | 2026-01-29 | Warnings, Adverse reactions | 847191 |
| .Insulin Aspart Protamine and Insulin Aspart | INSULIN ASPART | A-S Medication Solutions | 14499781-b90e-47d5-a7de-006965439b94 | 2024-02-22 | Warnings, Adverse reactions | 847191 |
| Insulin Aspart Protamine and Insulin Aspart Mix 70/30 | INSULIN ASPART | Novo Nordisk Pharma, Inc. | fc94baa4-3606-48bc-a781-9617ab6960ef | 2023-02-28 | Warnings, Adverse reactions | 847191 |
| NovoLog Mix 70/30 | INSULIN ASPART | Novo Nordisk | 1861fcee-7673-4afe-a206-08fa05c0add2 | 2023-02-28 | Warnings, Adverse reactions | 847191 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 19888a44-b330-462a-864d-338c5893dd63 | insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector [PSN] · 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [SCD] · insulin, aspart protamine, human 70 UNT/ML / insulin, aspart, human 30 UNT/ML per 3 ML Pen Injector [SY] | 3 | 32 | These highlights do not include all the information needed to use NOVOLOG MIX 70/30 safely and effectively. See full prescribing information for NOVOLOG MIX 70/30. NOVOLOG ® MIX 70/30 (insulin aspart protamine and insulin aspart) injectable suspension, for subcutaneous use Initial U.S. Approval: 2001 | 20260129 |
| 1861fcee-7673-4afe-a206-08fa05c0add2 | insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector [PSN] · 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [SCD] · insulin, aspart protamine, human 70 UNT/ML / insulin, aspart, human 30 UNT/ML per 3 ML Pen Injector [SY] | 3 | 24 | These highlights do not include all the information needed to use NOVOLOG MIX 70/30 safely and effectively. See full prescribing information for NOVOLOG MIX 70/30. NOVOLOG ® MIX 70/30 (insulin aspart protamine and insulin aspart) injectable suspension, for subcutaneous use Initial U.S. Approval: 2001 | 20230228 |
| 66da64f7-ca50-47d2-95fa-de37005eef85 | insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector [PSN] · 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [SCD] · insulin, aspart protamine, human 70 UNT/ML / insulin, aspart, human 30 UNT/ML per 3 ML Pen Injector [SY] | 3 | 14 | These highlights do not include all the information needed to use NOVOLOG MIX 70/30 safely and effectively. See full prescribing information for NOVOLOG MIX 70/30. NOVOLOG ® MIX 70/30 (insulin aspart protamine and insulin aspart) injectable suspension, for subcutaneous use Initial U.S. Approval: 2001 | 20260518 |
| 14499781-b90e-47d5-a7de-006965439b94 | insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector [PSN] · 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [SCD] · insulin, aspart protamine, human 70 UNT/ML / insulin, aspart, human 30 UNT/ML per 3 ML Pen Injector [SY] | 3 | 10 | These highlights do not include all the information needed to use INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 safely and effectively. See full prescribing information for INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30. INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 injectable suspension, for subcutaneous use Initial U.S. Approval: 2001 This product is NovoLog Mix 70/30 (insulin aspart protamine and insulin aspart). | 20240222 |
| 5d9f0e10-edb9-4960-bd62-cf406e75bbe7 | insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector [PSN] · 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [SCD] · insulin, aspart protamine, human 70 UNT/ML / insulin, aspart, human 30 UNT/ML per 3 ML Pen Injector [SY] | 3 | 9 | These highlights do not include all the information needed to use INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 safely and effectively. See full prescribing information for INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30. INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 injectable suspension, for subcutaneous use Initial U.S. Approval: 2001 This product is NovoLog Mix 70/30 (insulin aspart protamine and insulin aspart). | 20260407 |
| fc94baa4-3606-48bc-a781-9617ab6960ef | insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector [PSN] · 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [SCD] · insulin, aspart protamine, human 70 UNT/ML / insulin, aspart, human 30 UNT/ML per 3 ML Pen Injector [SY] | 3 | 7 | These highlights do not include all the information needed to use INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 safely and effectively. See full prescribing information for INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30. INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 injectable suspension, for subcutaneous use Initial U.S. Approval: 2001 This product is NovoLog Mix 70/30 (insulin aspart protamine and insulin aspart). | 20230228 |
| ead74453-dd15-4836-8ad6-5b14ac168d02 | insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector [PSN] · 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [SCD] · insulin, aspart protamine, human 70 UNT/ML / insulin, aspart, human 30 UNT/ML per 3 ML Pen Injector [SY] | 3 | 6 | These highlights do not include all the information needed to use NOVOLOG MIX 70/30 safely and effectively. See full prescribing information for NOVOLOG MIX 70/30. NOVOLOG ® MIX 70/30 (insulin aspart protamine and insulin aspart) injectable suspension, for subcutaneous use Initial U.S. Approval: 2001 | 20240124 |
| 973a9333-fec7-46dd-8eb5-25738f06ee54 | insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector [PSN] · 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [SCD] · insulin, aspart protamine, human 70 UNT/ML / insulin, aspart, human 30 UNT/ML per 3 ML Pen Injector [SY] | 3 | 2 | These highlights do not include all the information needed to use NovoLog Mix 70/30 safely and effectively. See full prescribing information for NovoLog Mix 70/30. NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]) Suspension for subcutaneous injection Initial U.S. Approval: 2001 | 20101108 |